Aurora kinase inhibitor LY3295668, Purity ≥98%

Synonym: LY3295668; 1919888-06-4; AK-01; LY-3295668; 1WX8O5XV4R; (2R,4R)-1-(3-Chloro-2-fluorobenzyl)-4-((3-fluoro-6-((5-methyl-1H-pyrazol-3-yl)amino)pyridin-2-yl)methyl)-2-methylpiperidine-4-carboxylic acid; Aurora A kinase inhibitor LY3295668; Aurora kinase inhibitor

CAS Number: 1919888-06-4
Compound CID: 121333423

Product Size

5 mg; 10 mg; 25 mg; 50 mg; 100 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

LY3295668, soluble in DMSO and ethanol and insoluble in water, is an Aurora kinase inhibitor that disrupts cell division processes. It targets Aurora A.

Molecular Weight

489.95

Molecular Formula

C₂₄H₂₆ClF₂N₅O₂

Targets

Aurora A: 0.8 nM

Form

Lyophilized powder

Purity

≥98%

Solubility

DMSO: 97 mg/mL (197.98 mM); Water: Insoluble; Ethanol: 15 mg/mL

Identity

Confirmed by NMR/HPLC/MS.

Stability

The product is stable for three years when stored at the recommended temperature in lyophilized powder.

Applications

LY3295668 can be used to study the selective inhibition of Aurora kinase A and its anti-tumor effects.

Storage

Store at -20ºC.